Correction: A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model
Ananda Mookerjee,
Michele Graciotti,
Lana E. Kandalaft
Affiliations
Ananda Mookerjee
Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, USA
Michele Graciotti
Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland; Department of Oncology, University Hospital of Lausanne, Lausanne, Switzerland
Lana E. Kandalaft
Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, USA
This corrects the article "A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model" published on 2018: Volume 08, Issue 03, Pages 211-221. Correction to: BioImpacts 10.15171/bi.2018.24, published on 2018: Volume 08, Issue 03 The original version of this article contained a typographical error in the spelling of the author Lana E. Kandalaft, which was incorrectly given as Lana Kandalaft. This has now been corrected in the PDF and HTML versions of the article.
